A61K 31/11
Aldehydes
A61K31/11 (Aldehydes) appears on 478 US grants and 787 published applications in this corpus.
Search patents in A61K- Granted patents
- 478
- Published applications
- 787
- Assignees
- 449
- Inventors
- 1,567
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 5 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 7 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 0 | 0 |
| 1991 | 3 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 9 | 0 |
| 1997 | 3 | 0 |
| 1998 | 6 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 9 | 0 |
| 2002 | 5 | 11 |
| 2003 | 7 | 18 |
| 2004 | 5 | 22 |
| 2005 | 4 | 18 |
| 2006 | 3 | 14 |
| 2007 | 4 | 14 |
| 2008 | 6 | 12 |
| 2009 | 2 | 23 |
| 2010 | 6 | 24 |
| 2011 | 11 | 23 |
| 2012 | 11 | 27 |
| 2013 | 13 | 29 |
| 2014 | 20 | 39 |
| 2015 | 20 | 32 |
| 2016 | 19 | 63 |
| 2017 | 32 | 47 |
| 2018 | 39 | 53 |
| 2019 | 36 | 52 |
| 2020 | 29 | 49 |
| 2021 | 30 | 37 |
| 2022 | 27 | 52 |
| 2023 | 17 | 33 |
| 2024 | 14 | 46 |
| 2025 | 22 | 33 |
| 2026 | 14 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Essential oil compositions and applications utilizing essential oils29 Sep 2026US 12,746,266 B2Ralco Nutrition, Inc.
- Composition for inhibiting Parkinson's disease and method of manufacturing the same1 Sep 2026US 12,721,824 B2Forte Capital Ltd.
- Compositions comprising cinnamaldehyde and zinc and methods of using such compositions4 Aug 2026US 12,697,353 B2Societe des Produits Nestle S. A.
- Composition for inhibiting diabetes mellitus and method of manufacturing the same4 Aug 2026US 12,697,363 B2Forte Capital Ltd.
- Pharmaceutical compositions for prevention and/or treatment of infections and antibacterial-induced dysfunctions30 Jun 2026US 12,668,830 B2European Molecular Biology Laboratory
- Enriched pelargonium graveolens extracts for the treatment of traumatic brain injuries6 Aug 2026US 2026/0224652 A1Sheba Impact Ltd.
- Methods and pharmaceutical compositions for the treatment of fibrosis with agents capable of inhibiting the activation of mucosal-associated invariant t (mait) cells23 Jul 2026US 2026/0209360 A1Assistance Publique-Hopitaux de Paris
- Compositions and methods for treatment of cancer using bacteria11 Jun 2026US 2026/0158079 A1Indaptus Therapeutics, Inc.
- Composition for enhancing adrenomedullin gene expression28 May 2026US 2026/0144780 A1House Wellness Foods Corporation
- Methods of administering enhanced delivery epinephrine and prodrug compositions to treat allergy23 Apr 2026US 2026/0108458 A1Aquestive Therapeutics, Inc.
Most cited
By later US patents
- Agent and product for the diagnosis and treatment of tumors and for the treatment of weaknesses of the cellular and humoral immune defense121US 5,021,234 A1991
- Bupropion as a modulator of drug activity118US 10,772,850 B2Antecip Bioventures II LLC · 2020
- Treatment of newborn jaundice100US 5,589,504 AAlbert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva University · 1996
- Acne vulgaris treatment regimen58US 8,679,552 B22014
- Deuterated compounds55US 5,149,820 ANorsk Hydro A/S · 1992